Study to Evaluate the Safety and Effectiveness of GP0116
Public ClinicalTrials.gov record NCT05987163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0116 for Correction of Moderate to Severe Dynamic Facial Wrinkles and Folds, Such as Nasolabial Folds.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, randomized, evaluator-blinded, comparator-controlled, parallel group, multicenter study in the U.S. for correction of moderate to severe dynamic facial wrinkles and folds, such as nasolabial folds (NLFs).
Study identification
- NCT ID
- NCT05987163
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 186 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 11, 2023
- Primary completion
- Oct 28, 2024
- Completion
- Mar 30, 2026
- Last update posted
- Jul 1, 2025
2023 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site (Site#8074) | Santa Monica | California | 90404 | — |
| Galderma Investigational Site (Site#8478) | Vista | California | 92083 | — |
| Galderma Investigational Site (Site#8680) | Westport | Connecticut | 06880 | — |
| Galderma Investigational Site (Site#8479) | Bradenton | Florida | 34209 | — |
| Galderma Investigational Site (Site#7030) | Coral Gables | Florida | 33134 | — |
| Galderma Investigational Site (Site#8284) | Coral Gables | Florida | 33146 | — |
| Galderma Investigational Site (Site#8126) | West Palm Beach | Florida | 33401 | — |
| Galderma Investigational Site (Site#7042) | Atlanta | Georgia | 30331 | — |
| Galderma Investigational Site (Site#8580) | New Orleans | Louisiana | 70130 | — |
| Galderma Investigational Site (Site#8481) | Chestnut Hill | Massachusetts | 02467 | — |
| Galderma Investigational Site (Site#8631) | Birmingham | Michigan | 48009 | — |
| Galderma Investigational Site (Site#8658) | New York | New York | 10021 | — |
| Galderma Investigational Site (Site#8482) | Chapel Hill | North Carolina | 27517 | — |
| Galderma Investigational Site (Site#8648) | Wilmington | North Carolina | 28405 | — |
| Galderma Investigational Site (Site#8783) | Cincinnati | Ohio | 45236 | — |
| Galderma Investigational Site (Site#8496) | Nashville | Tennessee | 37203 | — |
| Galderma Investigational Site (Site#8662) | Spring | Texas | 77388 | — |
| Galderma Investigational Site (Site#7047) | Arlington | Virginia | 22209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05987163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 1, 2025 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05987163 live on ClinicalTrials.gov.